WFDC2 and ovarian carcinoma: Another study comparing patients who developed invasive epithelial ovarian cancer with healthy controls suggests that a longitudinal multi-marker panel—including CA125, CA72-4, and HE4 (human epididymis protein 4)—is superior to CA125 alone in the early detection of ovarian cancer [45].